Article Text

Download PDFPDF

Administration of galacto-oligosaccharide prebiotics in the Flinders Sensitive Line animal model of depression
  1. Alexandra Bannach-Brown1,2,3,
  2. Sandra Tillmann1,
  3. Malcolm Robert MacLeod3,
  4. Gregers Wegener1
  1. 1 Department of Clinical Medicine, Translational Neuropsychiatry Unit, Aarhus University, Aarhus, Denmark
  2. 2 Centre for Research in Evidence-Based Medicine, Bond University, Gold Coast, Australia
  3. 3 Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
  1. Correspondence to Dr Alexandra Bannach-Brown, University of Edinburgh; a.bannach-brown{at}ed.ac.uk

Abstract

Introduction Major depressive disorder is the leading source of disability globally and current pharmacological treatments are less than adequate. Animal models such as the Flinders Sensitive Line (FSL) rats are used to mimic aspects of the phenotype in the human disorder and to characterise candidate antidepressant agents. Communication between the gut microbiome and the brain may play an important role in psychiatric disorders such as depression. Interventions targeting the gut microbiota may serve as potential treatments for depression, and this drives increasing research into the effect of probiotics and prebiotics in neuropsychiatric disorders. Prebiotics, galacto-oligosaccharides and fructooligosaccharides that stimulate the activity of gut bacteria have been reported to have a positive impact, reducing anxiety and depressive-like phenotypes and stress-related physiology in mice and rats, as well as in humans. Bimuno, the commercially available beta-galacto-oligosaccharide, has been shown to increase gut microbiota diversity.

Aim Here, we aim to investigate the effect of Bimuno on rat anxiety-like and depressive-like behaviour and gut microbiota composition in the FSL model, a genetic model of depression, in comparison to their control, the Flinders Resistant Line (FRL) rats.

Methods Sixty-four male rats aged 5–7 weeks, 32 FSL and 32 FRL rats, will be randomised to receive Bimuno or control (4 g/kg) daily for 4 weeks. Animals will be tested by an experimenter unaware of group allocation on the forced swim test to assessed depressive-like behaviour, the elevated plus maze to assess anxiety-like behaviour and the open field test to assess locomotion. Animals will be weighed and food and water intake, per kilogram of bodyweight, will be recorded. Faeces will be collected from each animal prior to the start of the experiment and on the final day to assess the bacterial diversity and relative abundance of bacterial genera in the gut. All outcomes and statistical analysis will be carried out blinded to group allocation, group assignments will be revealed after raw data have been uploaded to Open Science Framework. Two-way analysis of variance will be carried out to investigate the effect of treatment (control or prebiotic) and strain (FSL or FRL) on depressive-like and anxiety-like behaviours.

  • animal models of depression

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

View Full Text

Statistics from Altmetric.com

Review history and Supplementary material

  • Data Supplement

    Peer review history and previous versions

Footnotes

  • Data availability statement All data for each outcome will be made publicly available on OSF: https://osf.io/myc7s/

  • Funding ABB is supported by a scholarship from the Aarhus-Edinburgh Excellence in European Doctoral Education Project.

  • Competing interests None declared.

  • Ethics approval Ethics has been approved by Aarhus University Animal Ethics Committee (permission ID 2012-15-2934-00254).

  • Provenance and peer review Not commissioned, externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.